Mitesh

Class 4 Medicines Defect Information: Trazodone hydrochloride 50mg/5ml oral solution (Cygnus Pharma Ltd) Drug alert number: EL (24)A/16 Date issued: 20 May 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Trazodone hydrochloride 50mg/5ml oral solution (Cygnus Pharma Ltd) Company name: Cygnus Pharma Ltd Product name: [...]

The post MHRA Class 4 Medicines Notification: Trazodone hydrochloride 50mg/5ml oral solution (Cygnus Pharma Ltd) appeared first on Community Pharmacy England.

In light of surveillance data indicating that circulation of influenza in the community has returned to baseline levels, the Department of Health and Social Care has published an alert to inform prescribers working in primary care and pharmacy teams that antiviral medicines should no longer be prescribed.  Community pharmacists should no longer supply antiviral medicines [...]

The post End of antiviral medicine prescribing for 2023/24 influenza season appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 9 April 2024) has been published and includes articles on: Finasteride: reminder of the risk of psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment) Montelukast: reminder of the risk of neuropsychiatric reactions Letters [...]

The post MHRA Drug Safety Update: April 2024 appeared first on Community Pharmacy England.

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 10 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 May 2024. This takes the total [...]

The post 10 products added to the Discount Not Deducted (DND) list from May 2024 appeared first on Community Pharmacy England.

Drug alert number: EL (24)A/12 Date issued: 10 April 2024 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Co-Codamol 8/500mg Effervescent tablets (Accord-UK Ltd (Key Pharmaceuticals Livery)) PL 0142/1258 SNOMED Code: 42596911000001102 Batch No Expiry Date Pack Size First Distributed G2301502 08/2025 8 x 4 tablets 08-Dec-2023 [...]

The post MHRA Class 3 Medicines Recall: Co-Codamol 8/500mg Effervescent tablets (Accord-UK Ltd (Key Pharmaceuticals Livery)) appeared first on Community Pharmacy England.